Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 83 total PSOs listed by AHRQ.

ECRI Institute PSO
PSO Number: P0008
Component of Parent Org(s):
  • ECRI Institute
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 5200 Butler Pike, Plymouth Meeting, Pennsylvania 19462
PSO Phone Number: (866) 247-3004
Fax: (610) 567-1299
Point of Contact: Ronni P. Solomon
Point of Contact Phone: (610) 825-6000, ext. 5158
Point of Contact Email: rsolomon@ecri.org (link is external)
Next biennial attestation for Two Contracts due between 11/05/2018 and 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Vizient™ PSO
PSO Number: P0007
Component of Parent Org(s):
  • Vizient Inc
  • Vizient™ Data Services, LLC
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
Street Address: 155 North Wacker Drive, Suite 4000, Chicago, Illinois 60606
PSO Phone Number: (312) 775-4100
Fax: (312) 775-4580
Point of Contact: Ellen M. Flynn RN, MBA, JD
Point of Contact Phone: (312) 775-4292
Point of Contact Email: Ellen.Flynn@vizientinc.com (link is external)
Next biennial attestation for Two Contracts due between 11/05/2018 and 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No